Kapoor, Tyagi, Mohapatra, and Sharma: PRP therapy in chronic diffuse alopecia areata – A case report


Alopecia areata (AA) is an auto-immune disorder characterized by the appearance of non-scarring bald patches affecting the hair bearing areas of the body. 1 Hair loss can be patchy, confluent or diffuse, scalp being the most common site. Long standing AA can be extremely difficult to treat and has a poor prognosis. 2 Despite available therapeutic options, there has been a constant search for new, more effective hair restoration treatment. Platelet-rich plasma could be one such treatment. Growth factors in platelets’ granules of PRP bind in the bulge area of hair follicle, promoting hair growth thus making PRP a potential useful therapeutic tool for alopecias, without major adverse effects.3 Platelet-rich plasma (PRP) has been previously used to treat a variety of alopecias including AA with variable success rates. 4

We hereby, report a case of chronic diffuse AA showing excellent response to PRP therapy.

Case Summary

A 21-year old girl presented with asymptomatic loss of hair from the scalp for more than two years. At the onset, it started as small round patches of hair loss which gradually coalesced to involve whole of the scalp. There was no history of similar illness in family, no history of drug intake and no history suggestive of systemic illness.

On examination, there was patchy loss of hair involving the scalp with few small, thin light-coloured hair in the occipital region, no other body site was involved. On the basis of examination a diagnosis of chronic diffuse alopecia areata progressing to alopecia totalis was made, which was confirmed by doing a skin biopsy for Histopathological examination from the sample taken from occipital scalp. Histopathology stained section showed epidermis and dermis with miniaturised hair follicles surrounded by variable inflammatory lymphohistiocytic infiltrate [Fig 1-2].

Patient had given history of undergoing treatment previously with no response. As a primary approach the girl was started on oral corticosteroids in the form of oral mini pulse therapy (Betamethasone 5 mg as a single morning dose after breakfast on 2 consecutive days in a week for 3 months and then tapered off over next 3 months), 5 topical clobetasol propionate 0.05% lotion, topical 5% minoxidil solution and vitamin supplements. In addition to OMP, Azathioprine 50 mg daily was added after 3 months as the response to treatment was very slow and frequently relapsing. Partial regrowth of thin hair was noted in some areas of scalp at 6 months but was short lasting even with the ongoing treatment. In addition to this, intralesional triamcinolone acetonide injections (TCA) were started in completely bald areas of scalp at 3 weekly intervals and continued for further 3 months. The response to treatment was still poor at the end of 1 year in the terms of relapses and appearance of new hair loss patches, which had an impact of the young girl’s psychological state and it led her to stop all the ongoing treatment.

Then it was decided to go off the track and give a trial with PRP therapy. Patient agreed to undertake the trial. No other adjuvant treatment was given as patient did not want to take it. A total of eight sessions of PRP therapy were given.

PRP was prepared using double spin technique 6 and sessions were repeated every 4 weeks. Dramatic response was noted after 2 sessions in the form of improvement in hair diameter and total volume. Resistant areas also started showing hair growth [Fig 4,5]. Patient has been under follow up since last one and a half years and hair growth is sustained.

Figure 1
Figure 2

E-scopic image before starting PRP therapy

Figure 3

E-scopic image after3 sessions of PRP therapy

Figure 4
Figure 5


There are a few studies assessing the role of PRP therapy in AA. First report to establish the efficacy of PRP as a treatment modality in AA was published by Trink et al in 2013. 7 This study showed PRP therapy to be superior to TCA and Placebo in growing pigmented hair in AA patches. Another study by Taieb et al showed PRP therapy to be effective in AA but inferior to Minoxidil. 8 Another study by Shumez et al compared PRP with TCA but there was no statistically significant difference between the two. 9 A study by Sukhbir Singh showed positive effect of PRP therapy in 20 subjects. 10 Another case report with ophiasis type AA resistant to intralesional steroid injections showed excellent response to PRP therapy. 11 In all these studies, the cases with patchy hair loss only were included. On the other hand, Ovidio and Roberto negated the role of PRP therapy in giving persistent results and preventing relapses in cases of chronic diffuse alopecia areata. 12 Previous studies have demonstrated beneficial role of PRP therapy in cases of patchy alopecia areata, in contrast ours was a case of chronic diffuse AA. Inspite of many treatment modalities tried for more than a year, the response was unsatisfactory. PRP therapy yielded amazing results in the form of hair growth over resistant areas and overall increase in pigmented hair which were sustained at one and a half year follow up. Our case was unique in the way that excellent response to PRP treatment was noted

  1. In a case of diffuse alopecia areata.

  2. In a case non- responsive to standard modalities.

  3. In a case with no other supportive treatment.

Another similar case of chronic diffuse AA reported by Mubki showed improvement in hair growth but here PRP therapy was combined with TCA.13

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Source of Funding




R Paus A E Olsen G A Messenger TB Fitzpatrick K Wolff AL Goldsmith AB Gilchrest SA Paller JD Leffell Hair growth disordersDermtology in General Medicine. 7th Edn.Mc-Graw-HillNew York200875377


A Alkhalifah A Alsantali E Wang KJ McElwee J Shapiro Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesisJ Am Acad Dermatol20106221778810.1016/j.jaad.2009.10.032


G Maria-Angeliki K Alexandros-Efstratios R Dimitris K Konstantinos Platelet-rich Plasma as a Potential Treatment for Noncicatricial AlopeciasInt J Trichology201572546310.4103/0974-7753.160098


ZJ Li HI Choi DK Choi KC Sohn M Im YJ Seo Autologous Platelet-Rich Plasma: A Potential Therapeutic Tool for Promoting Hair GrowthDermatol Surg2012721040610.1111/j.1524-4725.2012.02394.x


J S Pasricha L Kumrah Alopecia totalis treated with oral mini-pulse (OMP) therapy with betamethasoneIndian J Dermatol Venereol Leprol19966221069


R Dhurat MS Sukesh Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's PerspectiveJ Cutan Aesthet Surg2014741899710.4103/0974-2077.150734


A Trink E Sorbellini P Bezzola L Rodella R Rezzani Y Ramot A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areataBr J Dermatol20131693690410.1111/bjd.12397


M A El Taieb H Ibrahim E A Nada Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluationDermatol Ther201630110.1111/dth.12437


H Shumez Pvs Prasad P K Kaviarasan Intralesional platelet rich plasma vs Intralesional triamcinolone in the treatment of alopecia areata: a comparative studyInt J Med Res Health Sci20154111822


S Singh Role of platelet-rich plasma in chronic alopecia areata: Our centre experienceIndian J Plast Surg2015481579


Jeff Donovan Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)JAAD Case rep201515305710.1016/j.jdcr.2015.07.004


R Ovidio M Roberto Limited Effectiveness of Platelet-Rich-Plasma Treatment on Chronic Severe Alopecia Areata. Hair Ther Transplant2014411210.4172/2167-0951.1000116


T Mubki Platelet-rich plasma combined with intralesional triamcinolone acetonide for the treatment of alopecia areata: A case reportJ Dermatol Dermatol Surg201510.1016/j.jdds.2015.11.002


© This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 02-07-2021

Accepted : 02-09-2021

Available online : 11-12-2021

View Article

PDF File   Full Text Article

Copyright permission

Get article permission for commercial use


PDF File   XML File   ePub File

Digital Object Identifier (DOI)

Article DOI


Article Metrics

Article Access statistics

Viewed: 145

PDF Downloaded: 60

Open Abstract (Increase article citation) Wiki in hindi